Bruno Stefania, Porta Stefano, Bussolati Benedetta
Department of Biotechnology and Health Sciences, Molecular Biotechnology Center; University of Turin, Italy.
Department of Biotechnology and Health Sciences, Molecular Biotechnology Center; University of Turin, Italy.
Eur J Pharmacol. 2016 Nov 5;790:83-91. doi: 10.1016/j.ejphar.2016.06.058. Epub 2016 Jul 1.
Extracellular vesicles (EVs) appear as important actors in cell-to-cell communication. EV content is characterized by proteins and RNA species that dynamically reflect cell and tissue state. Urinary EVs in particular may act in inter-nephron communication with possible beneficial or detrimental effects. Increasing interest is addressed to the pharmacological properties of EVs as a cell-free therapy, since several of the effects crAQ/tgqcedited to stem cells have been recapitulated by administration of their EVs. Preclinical data in models of renal damage indicate a general regenerative potential of EVs derived from mesenchymal stromal cells of different sources, including bone marrow, fetal tissues, urine and kidney. In this review we will discuss the results on the effect of EVs in repair of acute and chronic renal injury, and the mechanisms involved. In addition, we will analyse the strategies for EV pharmacological applications in renal regenerative medicine and limits and benefits involved.
细胞外囊泡(EVs)似乎是细胞间通讯的重要参与者。EVs的内容物以蛋白质和RNA种类为特征,这些蛋白质和RNA种类动态反映细胞和组织状态。特别是尿液中的EVs可能在肾单位间通讯中发挥作用,具有潜在的有益或有害影响。由于干细胞的一些效应已通过给予其EVs而得到重现,因此人们对EVs作为一种无细胞疗法的药理特性越来越感兴趣。肾损伤模型的临床前数据表明,来自不同来源(包括骨髓、胎儿组织、尿液和肾脏)的间充质基质细胞衍生的EVs具有一般的再生潜力。在这篇综述中,我们将讨论EVs对急性和慢性肾损伤修复作用的研究结果及其相关机制。此外,我们还将分析EVs在肾脏再生医学中的药理应用策略以及其中涉及的局限性和益处。